Search Results

Return to List
Results 1–17 of 17
Title Date
1.

Cell-free DNA Screening for Fetal Aneuploidy

Number 640

(Published Electronically Ahead of Print on June 26, 2015)
(This Committee Opinion Replaces Committee Opinion Number 545)

September 2015

PDF Format
2.

Management of Women With Phenylketonuria

Number 636

(Replaces Committee Opinion Number 449, December 2009)

June 2015

PDF Format
3.

Labor Induction or Augmentation and Autism

Number 597

May 2014

PDF Format
4.

Maternal–Fetal Surgery for Myelomeningocele

Number 550

January 2013

PDF Format
5.

Noninvasive Prenatal Testing for Fetal Aneuploidy

Number 545

December 2012

PDF Format
6.

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

July 2011

PDF Format
7.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

Reaffirmed 2013

June 2011

PDF Format
8.

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

April 2011

PDF Format
9.

Family History as a Risk Assessment Tool

Number 478

(Reaffirmed 2015)

March 2011

PDF Format
10.

Carrier Screening for Fragile X Syndrome

Number 469

(Reaffirmed 2014, Replaces No. 338, June 2006)

October 2010

PDF Format
11.

Moderate Caffeine Consumption During Pregnancy

Number 462

Reaffirmed 2013

August 2010

PDF Format
12.

Air Travel During Pregnancy

Number 443

(Reaffirmed 2014, Replaces No. 264, December 2001)

October 2009

PDF Format
13.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

October 2009

PDF Format
14.

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

March 2009

PDF Format
15.

Guidelines for Diagnostic Imaging During Pregnancy

Number 299

(Replaces No. 158, September 1995, Reaffirmed 2014 )

September 2004

PDF Format
16.

Avoiding Inappropriate Clinical Decisions Based on False-Positive Human Chorionic Gonadotropin Test Results

Number 278

(Reaffirmed 2015)

November 2002

PDF Format
17.

Management of Asymptomatic Pregnant or Lactating Women Exposed to Anthrax

Number 268

(Reaffirmed 2009)

February 2002

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998